{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:12:50Z","timestamp":1783926770195,"version":"3.55.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41380-026-03586-4","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T10:20:21Z","timestamp":1775298021000},"page":"4716-4726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis"],"prefix":"10.1038","volume":"31","author":[{"given":"Xi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-3568","authenticated-orcid":false,"given":"Ole","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cali","family":"Bartholomeusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-3987","authenticated-orcid":false,"given":"Stefan","family":"Borgwardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5666-3485","authenticated-orcid":false,"given":"Sunah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Colibazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-5141","authenticated-orcid":false,"given":"Rebecca","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-4353","authenticated-orcid":false,"given":"Cheryl","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1642","authenticated-orcid":false,"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2590-5055","authenticated-orcid":false,"given":"Bj\u00f8rn","family":"Ebdrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-0841","authenticated-orcid":false,"given":"Adriana","family":"Fortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3056-7262","authenticated-orcid":false,"given":"Birte Yding","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Birkedal","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-1050","authenticated-orcid":false,"given":"Shalaila","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-0949","authenticated-orcid":false,"given":"Holly","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8667-3107","authenticated-orcid":false,"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-1922","authenticated-orcid":false,"given":"Karsten","family":"Heekeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1148-8825","authenticated-orcid":false,"given":"Wenche","family":"ten Velden Hegelstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7764","authenticated-orcid":false,"given":"Michael","family":"Kaess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-4535","authenticated-orcid":false,"given":"Kiyoto","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Katagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-0817","authenticated-orcid":false,"given":"Minah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3375-236X","authenticated-orcid":false,"given":"Shinsuke","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-762X","authenticated-orcid":false,"given":"Tina","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-1462","authenticated-orcid":false,"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2444-5675","authenticated-orcid":false,"given":"Stephen","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-7445","authenticated-orcid":false,"given":"Jimmy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Loewy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-4974","authenticated-orcid":false,"given":"Daniel","family":"Mathalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-0122","authenticated-orcid":false,"given":"Paul","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7318-7377","authenticated-orcid":false,"given":"Takahiro","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9008-6757","authenticated-orcid":false,"given":"Jayachandra","family":"Raghava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-4119","authenticated-orcid":false,"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4956-2808","authenticated-orcid":false,"given":"Luis","family":"Rivera-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-7438","authenticated-orcid":false,"given":"Daiki","family":"Sasabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6055-8397","authenticated-orcid":false,"given":"Andre","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Smigielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-7862","authenticated-orcid":false,"given":"Gisela","family":"Sugranyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3213-6183","authenticated-orcid":false,"given":"Tsutomu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9191-6764","authenticated-orcid":false,"given":"Christian","family":"Tamnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4792-385X","authenticated-orcid":false,"given":"Anastasia","family":"Theodoridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordina","family":"Tor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-2224","authenticated-orcid":false,"given":"Peter","family":"Uhlhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"V\u00e6rnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Via","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Vinogradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-3719","authenticated-orcid":false,"given":"James","family":"Waltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-956X","authenticated-orcid":false,"given":"Lars","family":"Westlye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5919","authenticated-orcid":false,"given":"Stephen","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-6317","authenticated-orcid":false,"given":"Hidenori","family":"Yamasue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-9791","authenticated-orcid":false,"given":"Alison","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-8648","authenticated-orcid":false,"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-6788","authenticated-orcid":false,"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6667-7928","authenticated-orcid":false,"given":"Romina","family":"Mizrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0029-1525","authenticated-orcid":false,"given":"Vanessa","family":"Cropley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6574-9432","authenticated-orcid":false,"given":"Maria","family":"Jalbrzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-9292","authenticated-orcid":false,"given":"David E. J.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-5756","authenticated-orcid":false,"given":"Dennis","family":"Hernaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ENIGMA Clinical High Risk for Psychosis Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenche","family":"ten Velden Hegelstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"van Amelsvoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"3586_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","volume":"70","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-R\u00f6ssler A, Schultze-Lutter F, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70:107\u201320.","journal-title":"JAMA Psychiatry"},{"key":"3586_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eurpsy.2015.01.010","volume":"30","author":"F Schultze-Lutter","year":"2015","unstructured":"Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RKR, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 2015;30:405\u201316.","journal-title":"Eur Psychiatry"},{"key":"3586_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamapsychiatry.2021.0830","volume":"78","author":"G Salazar de Pablo","year":"2021","unstructured":"Salazar de Pablo G, Radua J, Pereira J, Bonoldi I, Arienti V, Besana F, et al. Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis. JAMA Psychiatry. 2021;78:970\u20138.","journal-title":"JAMA Psychiatry"},{"key":"3586_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jamapsychiatry.2021.0638","volume":"78","author":"M Jalbrzikowski","year":"2021","unstructured":"Jalbrzikowski M, Hayes RA, Wood SJ, Nordholm D, Zhou JH, Fusar-Poli P, et al. Association of structural magnetic resonance imaging measures with psychosis onset in individuals at clinical high risk for developing psychosis: an ENIGMA working group mega-analysis. JAMA Psychiatry. 2021;78:753\u201366.","journal-title":"JAMA Psychiatry"},{"key":"3586_CR5","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41380-022-01870-7","volume":"28","author":"MA Collins","year":"2023","unstructured":"Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, et al. Accelerated cortical thinning precedes and predicts conversion to psychosis: the NAPLS3 longitudinal study of youth at clinical high-risk. Mol Psychiatry. 2023;28:1182\u20139.","journal-title":"Mol Psychiatry"},{"key":"3586_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/schbul\/sbp151","volume":"37","author":"WH Jung","year":"2011","unstructured":"Jung WH, Kim JS, Jang JH, Choi JS, Jung MH, Park JY, et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull. 2011;37:839\u201349.","journal-title":"Schizophr Bull"},{"key":"3586_CR7","doi-asserted-by":"publisher","first-page":"E461","DOI":"10.1503\/jpn.230081","volume":"48","author":"S Sun","year":"2023","unstructured":"Sun S, Xiao S, Guo Z, Gong J, Tang G, Huang L, et al. Meta-analysis of cortical thickness reduction in adult schizophrenia. J Psychiatry Neurosci. 2023;48:E461\u2013e470.","journal-title":"J Psychiatry Neurosci"},{"key":"3586_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.biopsych.2018.04.023","volume":"84","author":"TGM van Erp","year":"2018","unstructured":"van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. 2018;84:644\u201354.","journal-title":"Biol Psychiatry"},{"key":"3586_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/schbul\/sbaa169","volume":"47","author":"M Kirschner","year":"2021","unstructured":"Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, et al. Orbitofrontal-striatal structural alterations linked to negative symptoms at different stages of the schizophrenia spectrum. Schizophr Bull. 2021;47:849\u201363.","journal-title":"Schizophr Bull"},{"key":"3586_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/archgenpsychiatry.2011.88","volume":"68","author":"NEM van Haren","year":"2011","unstructured":"van Haren NEM, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry. 2011;68:871\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"3586_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archgenpsychiatry.2009.24","volume":"66","author":"AL Goldman","year":"2009","unstructured":"Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, et al. Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry. 2009;66:467\u201377.","journal-title":"Arch Gen Psychiatry"},{"key":"3586_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/cercor\/bhr380","volume":"23","author":"V Oertel-Kn\u00f6chel","year":"2012","unstructured":"Oertel-Kn\u00f6chel V, Kn\u00f6chel C, Rotarska-Jagiela A, Reinke B, Prvulovic D, Haenschel C, et al. Association between psychotic symptoms and cortical thickness reduction across the schizophrenia spectrum. Cereb Cortex. 2012;23:61\u201370.","journal-title":"Cereb Cortex"},{"key":"3586_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.schres.2012.08.028","volume":"141","author":"MS Byun","year":"2012","unstructured":"Byun MS, Kim JS, Jung WH, Jang JH, Choi JS, Kim SN, et al. Regional cortical thinning in subjects with high genetic loading for schizophrenia. Schizophr Res. 2012;141:197\u2013203.","journal-title":"Schizophr Res"},{"key":"3586_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/schizbullopen\/sgad019","volume":"4","author":"BN McGuigan","year":"2023","unstructured":"McGuigan BN, Santini T, Keshavan MS, Prasad KM. Gene expressions preferentially influence cortical thickness of human connectome project atlas parcellated regions in first-episode antipsychotic-na\u00efve psychoses. Schizophr Bull Open. 2023;4:sgad019.","journal-title":"Schizophr Bull Open"},{"key":"3586_CR15","doi-asserted-by":"publisher","first-page":"17089","DOI":"10.1073\/pnas.1308091110","volume":"110","author":"C-H Chen","year":"2013","unstructured":"Chen C-H, Fiecas M, Guti\u00e9rrez ED, Panizzon MS, Eyler LT, Vuoksimaa E, et al. Genetic topography of brain morphology. Proc Natl Acad Sci. 2013;110:17089\u201394.","journal-title":"Proc Natl Acad Sci"},{"key":"3586_CR16","doi-asserted-by":"publisher","first-page":"eaay6690","DOI":"10.1126\/science.aay6690","volume":"367","author":"KL Grasby","year":"2020","unstructured":"Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, et al. The genetic architecture of the human cerebral cortex. Science. 2020;367:eaay6690.","journal-title":"Science"},{"key":"3586_CR17","first-page":"265","volume":"20","author":"B Kolb","year":"2011","unstructured":"Kolb B, Gibb R. Brain plasticity and behaviour in the developing brain. J Can Acad Child Adolesc Psychiatry. 2011;20:265\u201376.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"3586_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","volume":"20","author":"J Stiles","year":"2010","unstructured":"Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev. 2010;20:327\u201348.","journal-title":"Neuropsychol Rev"},{"key":"3586_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fnsyn.2019.00033","volume":"11","author":"J Ojeda","year":"2019","unstructured":"Ojeda J, \u00c1vila A. Early actions of neurotransmitters during cortex development and maturation of reprogrammed neurons. Front Synaptic Neurosci. 2019;11:33.","journal-title":"Front Synaptic Neurosci"},{"key":"3586_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fcell.2020.00391","volume":"8","author":"L Xing","year":"2020","unstructured":"Xing L, Huttner WB. Neurotransmitters as modulators of neural progenitor cell proliferation during mammalian neocortex development. Front Cell Dev Biol. 2020;8:391.","journal-title":"Front Cell Dev Biol"},{"key":"3586_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32420-y","volume":"13","author":"JY Hansen","year":"2022","unstructured":"Hansen JY, Shafiei G, Vogel JW, Smart K, Bearden CE, Hoogman M, et al. Local molecular and global connectomic contributions to cross-disorder cortical abnormalities. Nat Commun. 2022;13:4682.","journal-title":"Nat Commun"},{"key":"3586_CR22","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","volume":"25","author":"JY Hansen","year":"2022","unstructured":"Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, N\u00f8rgaard M, et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci. 2022;25:1569\u201381.","journal-title":"Nat Neurosci"},{"key":"3586_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1073\/pnas.0606722104","volume":"104","author":"F C\u00f4t\u00e9","year":"2007","unstructured":"C\u00f4t\u00e9 F, Fligny C, Bayard E, Launay JM, Gershon MD, Mallet J, et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA. 2007;104:329\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3586_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tins.2005.03.010","volume":"28","author":"A Represa","year":"2005","unstructured":"Represa A, Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci. 2005;28:278\u201383.","journal-title":"Trends Neurosci"},{"key":"3586_CR25","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1113\/jphysiol.2008.167635","volume":"587","author":"DD Wang","year":"2009","unstructured":"Wang DD, Kriegstein AR. Defining the role of GABA in cortical development. J Physiol. 2009;587:1873\u20139.","journal-title":"J Physiol"},{"key":"3586_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306990120","volume":"120","author":"Z Liao","year":"2023","unstructured":"Liao Z, Banaschewski T, Bokde ALW, Desrivi\u00e8res S, Flor H, Grigis A, et al. Hemispheric asymmetry in cortical thinning reflects intrinsic organization of the neurotransmitter systems and homotopic functional connectivity. Proc Natl Acad Sci USA. 2023;120:e2306990120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3586_CR27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83843","volume":"12","author":"B H\u00e4nisch","year":"2023","unstructured":"H\u00e4nisch B, Hansen JY, Bernhardt BC, Eickhoff SB, Dukart J, Misic B, et al. Cerebral chemoarchitecture shares organizational traits with brain structure and function. eLife. 2023;12:e83843.","journal-title":"eLife"},{"key":"3586_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","volume":"74","author":"A Egerton","year":"2013","unstructured":"Egerton A, Chaddock CA, Winton-Brown TT, Bloomfield MA, Bhattacharyya S, Allen P, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013;74:106\u201312.","journal-title":"Biol Psychiatry"},{"key":"3586_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/mp.2011.20","volume":"16","author":"O Howes","year":"2011","unstructured":"Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011;16:885\u20136.","journal-title":"Mol Psychiatry"},{"key":"3586_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/schbul\/sby076","volume":"45","author":"N Rao","year":"2019","unstructured":"Rao N, Northoff G, Tagore A, Rusjan P, Kenk M, Wilson A, et al. Impaired prefrontal cortical dopamine release in schizophrenia during a cognitive task: a [11C]FLB 457 positron emission tomography study. Schizophr Bull. 2019;45:670\u20139.","journal-title":"Schizophr Bull"},{"key":"3586_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein M, van de Giessen E, Van Snellenberg J, Thompson JL, Narendran R, Gil R, et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry. 2015;72:316\u201324.","journal-title":"JAMA Psychiatry"},{"key":"3586_CR32","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0269881111409265","volume":"26","author":"A Abi-Dargham","year":"2012","unstructured":"Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, et al. Increased prefrontal cortical D\u2081 receptors in drug naive patients with schizophrenia: a PET study with [\u00b9\u00b9C]NNC112. J Psychopharmacol. 2012;26:794\u2013805.","journal-title":"J Psychopharmacol"},{"key":"3586_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neulet.2018.03.007","volume":"691","author":"S Cervenka","year":"2019","unstructured":"Cervenka S. PET radioligands for the dopamine D1-receptor: application in psychiatric disorders. Neurosci Lett. 2019;691:26\u201334.","journal-title":"Neurosci Lett"},{"key":"3586_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41380-021-01349-x","volume":"27","author":"P Plav\u00e9n-Sigray","year":"2022","unstructured":"Plav\u00e9n-Sigray P, Ikonen Victorsson P, Santillo A, Matheson GJ, Lee M, Collste K, et al. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis. Mol Psychiatry. 2022;27:1233\u201340.","journal-title":"Mol Psychiatry"},{"key":"3586_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/archpsyc.62.4.371","volume":"62","author":"J Hirvonen","year":"2005","unstructured":"Hirvonen J, van Erp TG, Huttunen J, Aalto S, N\u00e5gren K, Huttunen M, et al. Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry. 2005;62:371\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"3586_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0071-9","volume":"8","author":"JP Kesby","year":"2018","unstructured":"Kesby JP, Eyles DW, McGrath JJ, Scott JG. Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry. 2018;8:30.","journal-title":"Transl Psychiatry"},{"key":"3586_CR37","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.biopsych.2020.06.027","volume":"89","author":"KB Bojesen","year":"2021","unstructured":"Bojesen KB, Broberg BV, Fagerlund B, Jessen K, Thomas MB, Sigvard A, et al. Associations between cognitive function and levels of glutamatergic metabolites and gamma-aminobutyric acid in antipsychotic-na\u00efve patients with schizophrenia or psychosis. Biol Psychiatry. 2021;89:278\u201387.","journal-title":"Biol Psychiatry"},{"key":"3586_CR38","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1017\/S0033291719002277","volume":"50","author":"KB Bojesen","year":"2020","unstructured":"Bojesen KB, Ebdrup BH, Jessen K, Sigvard A, Tangmose K, Edden RAE, et al. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-na\u00efve patients with psychosis. Psychol Med. 2020;50:2182\u201393.","journal-title":"Psychol Med"},{"key":"3586_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S1461145712000314","volume":"16","author":"C de la Fuente-Sandoval","year":"2013","unstructured":"de la Fuente-Sandoval C, Le\u00f3n-Ortiz P, Azc\u00e1rraga M, Favila R, Stephano S, Graff-Guerrero A. Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. Int J Neuropsychopharmacol. 2013;16:471\u20135.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3586_CR40","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bpsgos.2022.05.004","volume":"3","author":"AK Sigvard","year":"2023","unstructured":"Sigvard AK, Bojesen KB, Ambrosen KS, Nielsen M, Gjedde A, Tangmose K, et al. Dopamine synthesis capacity and gaba and glutamate levels separate antipsychotic-na\u00efve patients with first-episode psychosis from healthy control subjects in a multimodal prediction model. Biol Psychiatry Glob Open Sci. 2023;3:500\u20139.","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"3586_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1176\/appi.ajp.2014.13030418","volume":"172","author":"A Lin","year":"2015","unstructured":"Lin A, Wood SJ, Nelson B, Beavan A, McGorry P, Yung AR. Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am J Psychiatry. 2015;172:249\u201358.","journal-title":"Am J Psychiatry"},{"key":"3586_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00406-016-0764-8","volume":"268","author":"C Michel","year":"2018","unstructured":"Michel C, Ruhrmann S, Schimmelmann BG, Klosterk\u00f6tter J, Schultze-Lutter F. Course of clinical high-risk states for psychosis beyond conversion. Eur Arch Psychiatry Clin Neurosci. 2018;268:39\u201348.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3586_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbs136","volume":"40","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophrenia Bull. 2012;40:120\u201331.","journal-title":"Schizophrenia Bull"},{"key":"3586_CR44","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/S2045796021000639","volume":"31","author":"G Salazar de Pablo","year":"2022","unstructured":"Salazar de Pablo G, Soardo L, Cabras A, Pereira J, Kaur S, Besana F, et al. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis. Epidemiol Psychiatr Sci. 2022;31:e9.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"3586_CR45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.biopsych.2022.10.012","volume":"93","author":"D Erritzoe","year":"2023","unstructured":"Erritzoe D, Godlewska BR, Rizzo G, Searle GE, Agnorelli C, Lewis Y, et al. Brain serotonin release is reduced in patients with depression: a [11c]cimbi-36 positron emission tomography study with a d-amphetamine challenge. Biol Psychiatry. 2023;93:1089\u201398.","journal-title":"Biol Psychiatry"},{"key":"3586_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1176\/appi.ajp.2016.15101334","volume":"174","author":"S Moriguchi","year":"2017","unstructured":"Moriguchi S, Yamada M, Takano H, Nagashima T, Takahata K, Yokokawa K, et al. Norepinephrine transporter in major depressive disorder: a PET study. Am J Psychiatry. 2017;174:36\u201341.","journal-title":"Am J Psychiatry"},{"key":"3586_CR47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","volume":"12","author":"KJ Ressler","year":"2000","unstructured":"Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12:2\u201319.","journal-title":"Depress Anxiety"},{"key":"3586_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00213-007-0921-x","volume":"195","author":"R Hurlemann","year":"2008","unstructured":"Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, et al. 5-HT2A receptor density is decreased in the at-risk mental state. Psychopharmacol. 2008;195:579\u201390.","journal-title":"Psychopharmacol"},{"key":"3586_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03336-0","volume":"15","author":"L Tuominen","year":"2025","unstructured":"Tuominen L, Armio RL, Hansen JY, Walta M, Koutsouleris N, Laurikainen H, et al. Molecular, physiological and functional features underlying antipsychotic medication use related cortical thinning. Transl Psychiatry. 2025;15:129.","journal-title":"Transl Psychiatry"},{"key":"3586_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jamapsychiatry.2020.0036","volume":"77","author":"AN Voineskos","year":"2020","unstructured":"Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, et al. Effects of antipsychotic medication on brain structure in patients with major depressive disorder and psychotic features: neuroimaging findings in the context of a randomized placebo-controlled clinical trial. JAMA Psychiatry. 2020;77:674\u201383.","journal-title":"JAMA Psychiatry"},{"key":"3586_CR51","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","volume":"39","author":"AR Yung","year":"2005","unstructured":"Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell\u2019Olio M, et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry. 2005;39:964\u201371.","journal-title":"Aust N Z J Psychiatry"},{"key":"3586_CR52","unstructured":"McGlashan T, Miller T, Woods S, Rosen J, Hoffman R, Davidson L Structured interview for prodromal syndromes (SIPS). New Haven: Yale University 2001."},{"key":"3586_CR53","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/schbul\/12.4.578","volume":"12","author":"D Lukoff","year":"1986","unstructured":"Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull. 1986;12:578\u2013602.","journal-title":"Schizophr Bull"},{"key":"3586_CR54","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/schbul\/sbab005","volume":"47","author":"M Antoniades","year":"2021","unstructured":"Antoniades M, Haas SS, Modabbernia A, Bykowsky O, Frangou S, Borgwardt S, et al. Personalized estimates of brain structural variability in individuals with early psychosis. Schizophr Bull. 2021;47:1029\u201338.","journal-title":"Schizophr Bull"},{"key":"3586_CR55","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41380-021-01359-9","volume":"27","author":"M Kirschner","year":"2022","unstructured":"Kirschner M, Hodzic-Santor B, Antoniades M, Nenadic I, Kircher T, Krug A, et al. Cortical and subcortical neuroanatomical signatures of schizotypy in 3004 individuals assessed in a worldwide ENIGMA study. Mol Psychiatry. 2022;27:1167\u201376.","journal-title":"Mol Psychiatry"},{"key":"3586_CR56","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.1017\/S0033291723000223","volume":"53","author":"SR McWhinney","year":"2023","unstructured":"McWhinney SR, Ab\u00e9 C, Alda M, Benedetti F, B\u00f8en E, del Mar Bonnin C, et al. Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants. Psychological Med. 2023;53:6743\u201353.","journal-title":"Psychological Med"},{"key":"3586_CR57","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968\u201380.","journal-title":"Neuroimage"},{"key":"3586_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116956","volume":"218","author":"J Radua","year":"2020","unstructured":"Radua J, Vieta E, Shinohara R, Kochunov P, Quid\u00e9 Y, Green MJ, et al. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA. Neuroimage. 2020;218:116956.","journal-title":"Neuroimage"},{"key":"3586_CR59","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuroimage.2018.05.070","volume":"178","author":"AF Alexander-Bloch","year":"2018","unstructured":"Alexander-Bloch AF, Shou H, Liu S, Satterthwaite TD, Glahn DC, Shinohara RT, et al. On testing for spatial correspondence between maps of human brain structure and function. Neuroimage. 2018;178:540\u201351.","journal-title":"Neuroimage"},{"key":"3586_CR60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Society: Ser B (Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Society: Ser B (Methodol"},{"key":"3586_CR61","first-page":"171","volume":"7","author":"K Aberizk","year":"2022","unstructured":"Aberizk K, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, et al. Life event stress and reduced cortical thickness in youth at clinical high risk for psychosis and healthy control subjects. Biol Psychiatry: Cognit Neurosci Neuroimaging. 2022;7:171\u20139.","journal-title":"Biol Psychiatry: Cognit Neurosci Neuroimaging"},{"key":"3586_CR62","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrn.2017.125","volume":"18","author":"R Birnbaum","year":"2017","unstructured":"Birnbaum R, Weinberger DR. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci. 2017;18:727\u201340.","journal-title":"Nat Rev Neurosci"},{"key":"3586_CR63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.biopsych.2024.03.011","volume":"96","author":"J Gonz\u00e1lez-Pe\u00f1as","year":"2024","unstructured":"Gonz\u00e1lez-Pe\u00f1as J, Alloza C, Brouwer R, D\u00edaz-Caneja CM, Costas J, Gonz\u00e1lez-Lois N, et al. Accelerated cortical thinning in schizophrenia is associated with rare and common predisposing variation to schizophrenia and neurodevelopmental disorders. Biol Psychiatry. 2024;96:376\u201389.","journal-title":"Biol Psychiatry"},{"key":"3586_CR64","doi-asserted-by":"publisher","first-page":"15846","DOI":"10.3390\/ijms232415846","volume":"23","author":"A Mayeli","year":"2022","unstructured":"Mayeli A, Sonnenschein SF, Yushmanov VE, Wilson JD, Blazer A, Foran W, et al. Dorsolateral prefrontal cortex glutamate\/gamma-aminobutyric acid (GABA) alterations in clinical high risk and first-episode schizophrenia: a preliminary 7-t magnetic resonance spectroscopy imaging study. Int J Mol Sci. 2022;23:15846.","journal-title":"Int J Mol Sci"},{"key":"3586_CR65","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41380-021-01297-6","volume":"27","author":"T Nakahara","year":"2022","unstructured":"Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M, et al. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of (1)H-magnetic resonance spectroscopy studies. Mol Psychiatry. 2022;27:744\u201357.","journal-title":"Mol Psychiatry"},{"key":"3586_CR66","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","volume":"168","author":"OD Howes","year":"2011","unstructured":"Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168:1311\u20137.","journal-title":"Am J Psychiatry"},{"key":"3586_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102265","volume":"213","author":"CFM van Hooijdonk","year":"2022","unstructured":"van Hooijdonk CFM, Drukker M, van de Giessen E, Booij J, Selten J-P, van Amelsvoort TAMJ. Dopaminergic alterations in populations at increased risk for psychosis: a systematic review of imaging findings. Prog Neurobiol. 2022;213:102265.","journal-title":"Prog Neurobiol"},{"key":"3586_CR68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.biopsych.2024.01.019","volume":"96","author":"JJ Weinstein","year":"2024","unstructured":"Weinstein JJ, Moeller SJ, Perlman G, Gil R, Van Snellenberg JX, Wengler K, et al. Imaging the vesicular acetylcholine transporter in schizophrenia: a positron emission tomography study using [18F]-VAT. Biol Psychiatry. 2024;96:352\u201364.","journal-title":"Biol Psychiatry"},{"key":"3586_CR69","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41380-025-03229-0","volume":"31","author":"KB Bojesen","year":"2025","unstructured":"Bojesen KB, Ambrosen KS, Sigvard AK, Nielsen M, Gjedde A, Kumakura Y, et al. Interrelations between dopaminergic-, gabaergic- and glutamatergic neurotransmitters in antipsychotic-na\u00efve psychosis patients and the association to initial treatment response. Mol Psychiatry. 2025;31:1231\u201340.","journal-title":"Mol Psychiatry"},{"key":"3586_CR70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.biopsych.2022.06.017","volume":"92","author":"OD Howes","year":"2022","unstructured":"Howes OD, Shatalina E. Integrating the neurodevelopmental and dopamine hypotheses of schizophrenia and the role of cortical excitation-inhibition balance. Biol Psychiatry. 2022;92:501\u201313.","journal-title":"Biol Psychiatry"},{"key":"3586_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02800-7","volume":"14","author":"Q Wu","year":"2024","unstructured":"Wu Q, Long Y, Peng X, Song C, Xiao J, Wang X, et al. Prefrontal cortical dopamine deficit may cause impaired glucose metabolism in schizophrenia. Transl Psychiatry. 2024;14:79.","journal-title":"Transl Psychiatry"},{"key":"3586_CR72","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/sj.npp.1301285","volume":"32","author":"M Sarter","year":"2007","unstructured":"Sarter M, Bruno JP, Parikh V. Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology. 2007;32:1452\u201361.","journal-title":"Neuropsychopharmacology"},{"key":"3586_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116298","volume":"228","author":"DL Uliana","year":"2024","unstructured":"Uliana DL, Lisboa JRF, Gomes FV, Grace AA. The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia. Biochemical Pharmacology. 2024;228:116298.","journal-title":"Biochemical Pharmacology"},{"key":"3586_CR74","first-page":"703","volume":"9","author":"KB Bojesen","year":"2024","unstructured":"Bojesen KB, Rostrup E, Sigvard AK, Mikkelsen M, Edden RAE, Ebdrup BH, et al. The trajectory of prefrontal GABA levels in initially antipsychotic-na\u00efve patients with psychosis during 2 years of treatment and associations with striatal cerebral blood flow and outcome. Biol Psychiatry: Cognit Neurosci Neuroimaging. 2024;9:703\u201313.","journal-title":"Biol Psychiatry: Cognit Neurosci Neuroimaging"},{"key":"3586_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neubiorev.2014.06.005","volume":"45","author":"S Selvaraj","year":"2014","unstructured":"Selvaraj S, Arnone D, Cappai A, Howes O. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev. 2014;45:233\u201345.","journal-title":"Neurosci Biobehav Rev"},{"key":"3586_CR76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","volume":"67","author":"H Rasmussen","year":"2010","unstructured":"Rasmussen H, Erritzoe D, Andersen R, Ebdrup BH, Aggernaes B, Oranje B, et al. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 2010;67:9\u201316.","journal-title":"Arch Gen Psychiatry"},{"key":"3586_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2215-0366(21)00386-2","volume":"9","author":"D Bugarski-Kirola","year":"2022","unstructured":"Bugarski-Kirola D, Arango C, Fava M, Nasrallah H, Liu IY, Abbs B, et al. Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe. Lancet Psychiatry. 2022;9:46\u201358.","journal-title":"Lancet Psychiatry"},{"key":"3586_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2023.115104","volume":"321","author":"B Romeo","year":"2023","unstructured":"Romeo B, Willaime L, Rari E, Benyamina A, Martelli C. Efficacy of 5-HT2A antagonists on negative symptoms in patients with schizophrenia: a meta-analysis. Psychiatry Res. 2023;321:115104.","journal-title":"Psychiatry Res"},{"key":"3586_CR79","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tins.2010.05.005","volume":"33","author":"EA Daubert","year":"2010","unstructured":"Daubert EA, Condron BG. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010;33:424\u201334.","journal-title":"Trends Neurosci"},{"key":"3586_CR80","doi-asserted-by":"publisher","first-page":"10752","DOI":"10.1523\/JNEUROSCI.2037-10.2010","volume":"30","author":"A Cheng","year":"2010","unstructured":"Cheng A, Scott AL, Ladenheim B, Chen K, Ouyang X, Lathia JD, et al. Monoamine oxidases regulate telencephalic neural progenitors in late embryonic and early postnatal development. J Neurosci. 2010;30:10752\u201362.","journal-title":"J Neurosci"},{"key":"3586_CR81","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/cercor\/bhl051","volume":"17","author":"C Altamura","year":"2007","unstructured":"Altamura C, Dell\u2019Acqua ML, Moessner R, Murphy DL, Lesch KP, Persico AM. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb Cortex. 2007;17:1394\u2013401.","journal-title":"Cereb Cortex"},{"key":"3586_CR82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-021-01137-9","volume":"47","author":"SM Kolk","year":"2022","unstructured":"Kolk SM, Rakic P. Development of prefrontal cortex. Neuropsychopharmacology. 2022;47:41\u201357.","journal-title":"Neuropsychopharmacology"},{"key":"3586_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104706","volume":"135","author":"E Saboory","year":"2020","unstructured":"Saboory E, Ghasemi M, Mehranfard N. Norepinephrine, neurodevelopment and behavior. Neurochemistry Int. 2020;135:104706.","journal-title":"Neurochemistry Int"},{"key":"3586_CR84","unstructured":"Kirschner M, Hodzic-Santor B, Kennedy L, Hansen JY, Antoniades M, Nenadi\u0107 I et al. Multiscale characterization of cortical signatures in positive and negative schizotypy: a worldwide ENIGMA study. medRxiv 2024.2005.2003.24306736 [Preprint]. 2024.Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.05.03.24306736v1."},{"key":"3586_CR85","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1476-5381.2009.00149.x","volume":"157","author":"CY Jin","year":"2009","unstructured":"Jin CY, Anichtchik O, Panula P. Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Br J Pharmacol. 2009;157:118\u201329.","journal-title":"Br J Pharmacol"},{"key":"3586_CR86","first-page":"564","volume":"10","author":"D Mahmood","year":"2016","unstructured":"Mahmood D. Histamine H(3) receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical & clinical perspective. Int J Health Sci. 2016;10:564\u201375.","journal-title":"Int J Health Sci"},{"key":"3586_CR87","doi-asserted-by":"crossref","unstructured":"Arumuham A, Shatalina E, Nour MM, Veronese M, Onwordi EC, Kaar SJ, et al. Working memory processes and the histamine-3 receptor in schizophrenia: a [11C]MK-8278 PET-fMRI study. Psychopharmacology. 2024.","DOI":"10.1007\/s00213-024-06730-6"},{"key":"3586_CR88","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1192\/bja.2019.21","volume":"25","author":"J Cookson","year":"2019","unstructured":"Cookson J. Histamine in psychiatry: promethazine as a sedative anticholinergic. BJPsych Adv. 2019;25:265\u20138.","journal-title":"BJPsych Adv"},{"key":"3586_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fpsyt.2012.00049","volume":"3","author":"MJ Fell","year":"2012","unstructured":"Fell MJ, Katner JS, Rasmussen K, Nikolayev A, Kuo MS, Nelson DL, et al. Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine h(1) receptor blockade. Front Psychiatry. 2012;3:49.","journal-title":"Front Psychiatry"},{"key":"3586_CR90","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.2174\/1381612821666150605105325","volume":"21","author":"BA Ellenbroek","year":"2015","unstructured":"Ellenbroek BA, Ghiabi B. Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia? Curr Pharm Des. 2015;21:3760\u201370.","journal-title":"Curr Pharm Des"},{"key":"3586_CR91","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuroimage.2018.04.054","volume":"176","author":"E Guma","year":"2018","unstructured":"Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu A, Lerch JP, et al. Regional brain volume changes following chronic antipsychotic administration are mediated by the dopamine D2 receptor. Neuroimage. 2018;176:226\u201338.","journal-title":"Neuroimage"},{"key":"3586_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43955-4","volume":"9","author":"E Guma","year":"2019","unstructured":"Guma E, Rocchetti J, Devenyi GA, Tanti A, Mathieu AP, Lerch JP, et al. Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration. Sci Rep. 2019;9:7850.","journal-title":"Sci Rep"},{"key":"3586_CR93","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8332","volume":"9","author":"AI Luppi","year":"2023","unstructured":"Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, et al. In vivo mapping of pharmacologically induced functional reorganization onto the human brain\u2019s neurotransmitter landscape. Sci Adv. 2023;9:eadf8332.","journal-title":"Sci Adv"},{"key":"3586_CR94","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0166-2236(96)01028-4","volume":"20","author":"P Levitt","year":"1997","unstructured":"Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 1997;20:269\u201374.","journal-title":"Trends Neurosci"},{"key":"3586_CR95","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1038\/s41380-022-01654-z","volume":"27","author":"D Liu","year":"2022","unstructured":"Liu D, Zinski A, Mishra A, Noh H, Park G-H, Qin Y, et al. Impact of schizophrenia GWAS loci converge onto distinct pathways in cortical interneurons vs glutamatergic neurons during development. Mol Psychiatry. 2022;27:4218\u201333.","journal-title":"Mol Psychiatry"},{"key":"3586_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43567-7","volume":"14","author":"E-M Stauffer","year":"2023","unstructured":"Stauffer E-M, Bethlehem RAI, Dorfschmidt L, Won H, Warrier V, Bullmore ET. The genetic relationships between brain structure and schizophrenia. Nat Commun. 2023;14:7820.","journal-title":"Nat Commun"},{"key":"3586_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111121","volume":"135","author":"H Wang","year":"2024","unstructured":"Wang H, Zhao Q, Zhang Y, Ma J, Lei M, Zhang Z, et al. Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry. 2024;135:111121.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"3586_CR98","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s12031-019-01324-w","volume":"68","author":"MV Alfimova","year":"2019","unstructured":"Alfimova MV, Kondratyev NV, Tomyshev AS, Lebedeva IS, Lezheiko TV, Kaleda VG, et al. Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness. J Mol Neurosci. 2019;68:658\u201366.","journal-title":"J Mol Neurosci"},{"key":"3586_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01771-3","volume":"12","author":"J Cabana-Dom\u00ednguez","year":"2022","unstructured":"Cabana-Dom\u00ednguez J, Torrico B, Reif A, Fern\u00e0ndez-Castillo N, Cormand B. Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. Transl Psychiatry. 2022;12:11.","journal-title":"Transl Psychiatry"},{"key":"3586_CR100","doi-asserted-by":"crossref","unstructured":"Warren TL, Tubbs JD, Lesh TA, Corona MB, Pakzad SS, Albuquerque MD, et al. Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis. Mol Psychiatry. 2024.","DOI":"10.1101\/2023.05.24.23290465"},{"key":"3586_CR101","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03586-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03586-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:03:03Z","timestamp":1783926183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03586-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3586"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03586-4","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ingrid Agartz acknowledges the Research Council of Norway (grant 223272), South-Eastern Norway Regional Health Authority, The Swedish Research Council, and Karolinska Institutet; Ole Andreassen has received grants 223273 and 283798 from the Research Council of Norway as well as grants from K. G. Jebsen Stiftelsen and UiO: Life Science; Inmaculada Baeza acknowledges Instituto de Salud Carlos III (INT19\/00021) for her support. IB, AF and JCP would like to thank ISCIII (PI11\/1349, PI15\/0444, PI180242), \u201cUna manera de hacer Europa\u201d; Stefan Borgwardt has received grants from the SYNSCHIZ project under the ERA-NET Horizon 2020 program; Tiziano Colibazzi has received grants 5T32MH15144 and K23 MH85063 from the National Institute of Mental Health as well as grants from the Brain and Behavior Research Foundation, Sackler Institute, Herbert Irving Scholar Award, and Columbia University Bodini Fellowship; Cheryl Corcoran is supported by R01MH107558 and R01MH115332 from the National Institutes of Health; Camilo de la Fuente-Sandoval is supported by grants 261895 and 320662 from the Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACyT), grants from CONACyT\u2019s Sistema Nacional de Investigadores (SNI), and grant R21 MH117434 from the National Institutes of Health; Bj\u00f8rn Ebdrup has received personal fees for serving on advisory boards from Eli Lilly Denmark, Janssen-Cilag, Lundbeck, and Takeda and has received lecture fees from Bristol Myers Squibb, Otsuka Pharma Scandinavia, Eli Lilly and Company, Boehringer Ingelheim Denmark, and Lundbeck; Birte Yding Glenth\u00f8j is supported by the Lundbeck Foundation Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research; Louise Birkedal Glenth\u00f8j is supported by the TrygFoundation; the Danish Research Council on Independent Research; the Lundbeck Foundation Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS; Shalaila Haas is supported by NIH National Institute of Mental Health, grant T32MH122394 Rebecca Hayes has received grants from the University of Pittsburgh Medical Center; Christine Hooker is supported by grant R01 MH105246 from the National Institutes of Health; Michael Kaess has received grants from German Federal Ministry of Education and Research, Swiss National Science Foundation, German Research Foundation, Dietmar Hopp Foundation, Baden-Wuerttemberg Foundation, and National Health, Medical and Research Council; Kiyoto Kasai and Shinsuke Koike have received support from Japan Agency for Medical Research and Development (AMED) under Grant Number JP18dm0307001, JP18dm0307004, and JP19dm0207069, and JST Moonshot R&D (JPMJMS2021); Minah Kim has received grant 2019R1C1C1002457 from the National Research Foundation of Korea and grant 21-BR-03-01 from the KBRI basic research program through Korea Brain Research Institute, funded by the Ministry of Science & ITC; Jochen Kindler has received grants from the Swiss National Science Foundation and Lundbeck Foundation; Tina Kristensen is supported by a Brain and Behavior Research Foundation 2021 NARSAD Young Investigator Grant (ID 30112); Jun Soo Kwon has received grant 2020M3E5D9079910 from the National Research Foundation of Korea and grant 21-BR-03-01 from the KBRI basic research program through Korea Brain Research Institute, funded by the Ministry of Science & ITC; Jimmy Lee has received grant NMRC\/TCR\/003\/2008 from the National Medical Research Council Translational and Clinical Research Flagship Programme; Ashleigh Lin is supported by a National Health and Medical Research Council (NHMRC) Emerging Leadership Fellowship 2010063; Rachel Loewy has received grants K23MH086618 and R01MH081051 from the National Institute of Mental Health; Daniel Mathalon has received grants from the Brain and Behavior Research Foundation and grant R01 MH076989 from the National Institute of Mental Health; Patrick McGorry has received multiple grants from the National Health and Medical Research Council; Takahiro Nemoto has received grants from Otsuka; Francisco Reyes-Madrigal was supported by grants from SNI; Wulf R\u00f6ssler has received grants from the Zurich Program for Sustainable Development of Mental Health Services; Daiki Sasabayashi has received grant JP18K15509 and JP22K15745 from the JSPS KAKENHI; Ulrich Schall has received grant 569259 from the National Health and Medical Research Council of Australia; Gisela Sugranyes is supported by the Fundaci\u00f3 Cl\u00ednic Recerca Biom\u00e8dica, the Brain and Behavior Research Foundation (NARSAD Young Investigator Award 2017, grant ID: 26731), the Alicia Koplowitz Foundation and the Spanish Ministry of Health, Instituto de Salud Carlos III \u201cHealth Research Fund\u201d (PI15\/0444; PI18\/0242; PI18\/00976; PI2100330); Tsutomu Takahashi is supported by JSPS KAKENHI Grant Number JP18K07550; Christian Tamnes is supported by the Research Council of Norway (#223273, #288083, #323951) and the South-Eastern Norway Regional Health Authority (#2019069, #2021070, #2023012, #500189); Jinsong Tang has received grant 81871057 from the National Natural Science Foundation of China; Jordina Tor has received grants PI11\/02684 and PI15\/00509 from the Instituto de Salud Carlos III; Peter Uhlhaas has received grant MR\/L011689\/1 from the UK Medical Research Council; James Waltz has received grant 5R01MH115031 from the National Institute of Mental Health; Lars Westlye has received European Union\u2019s Horizon 2020 Research and Innovation Program grant 802998 from the European Research Council; Stephen Wood has received grant 566529 and a Clinical Career Development Award (359223) from the National Health and Medical Research Council; Alison Yung has received multiple grants from the National Health and Medical Research Council; Juan Zhou has received grants from the Yong Loo Lin School of Medicine at the National University of Singapore; Paolo Fusar-Poli has received grant UK G0700995 from the UK Medical Research Council; Romina Mizrahi has received grants R01MH100043 and R01MH113564 from the National Institute of Mental Health and grants from the Brain and Behavior Research Foundation and Canadian Institutes of Health Research; Vanessa Cropley has received investigator grant 1177370 and project grant 1065742 from the National Health and Medical Research Council; Paul Thompson is supported in part by NIH grants R01MH123163, R01MH121246, and R01MH116147. Core funding for ENIGMA was provided by the NIH Big Data to Knowledge (BD2K) program under consortium grant U54 EB020403 to PMT; Maria Jalbrzikowski is supported by NIMH grants K01MH112774 and R01MH129636.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. All sites obtained local institutional review board approval. The Institutional Review Board (IRB) at the Boston Children\u2019s Hospital also approved the ENIGMA-CHR Repository (IRB-P00043549). Written informed consent was obtained from every participant, or from the participant\u2019s guardian for minors. All studies were conducted in accordance with the Declaration of Helsinki [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}